Altolyn cromolyn: Phase III start

Manhattan plans to begin a Phase III trial to compare the oral Altolyn cromolyn vs. placebo. Manhattan plans to submit a 505(b)(2) NDA for Altolyn with the reference product being an oral liquid formu...